Literature DB >> 1370125

Marek's disease virus-mediated enhancement of avian leukosis virus gene expression and virus production.

J T Pulaski1, V L Tieber, P M Coussens.   

Abstract

Direct interaction between two viruses in coinfected cells may promote replication and pathogenesis of one or both virus types. Synergism between herpesviruses and retroviruses is an important factor in diagnosis, treatment, and prevention of animal and human diseases. In birds, Marek's disease virus (MDV) may be an important cofactor in avian leukosis virus induced disease. Infection of susceptible cells with non-oncogenic serotype 2 MDV, an avian herpesvirus, and Rous-associated virus type 2 (RAV-2 ALV), a leukemogenic avian retrovirus, results in enhanced (greater than 3-fold) transcription of retroviral genes, relative to infection with ALV alone. A direct relationship between concentrations of retroviral gene expression and amount of input MDV suggests that MDV-encoded or -induced factors are responsible for enhanced ALV gene expression, ultimately leading to increased accumulation of ALV-specific RNA (greater than 5-fold) and protein (greater than 10-fold). At lower doses of input MDV, ALV virus production increased over 3-fold, relative to cells infected with ALV alone. Interactive laser cytometry was used to detect accumulation of both MDV and ALV antigens within single cells from coinfected cultures. These results suggest a direct role for MDV-encoded or -induced factors in enhancement of ALV gene expression and demonstrate the importance of herpesviruses as cofactors in retrovirus replication and pathogenesis in coinfected cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370125     DOI: 10.1016/0042-6822(92)90065-w

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Avian endogenous retrovirus EAV-HP shares regions of identity with avian leukosis virus subgroup J and the avian retrotransposon ART-CH.

Authors:  M A Sacco; D M Flannery; K Howes; K Venugopal
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.

Authors:  E Le Rouzic; B Perbal
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek's disease virus.

Authors:  R W Morgan; L Sofer; A S Anderson; E L Bernberg; J Cui; J Burnside
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 4.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  The U3 region of the long terminal repeat of a subgroup A transformation-defective rous sarcoma virus (tdPH2010) converts a noncytopathic virus to a cytopathic virus.

Authors:  H Hara; A Kaji
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

6.  Endogenous Avian Leukosis Virus in Combination with Serotype 2 Marek's Disease Virus Significantly Boosted the Incidence of Lymphoid Leukosis-Like Bursal Lymphomas in Susceptible Chickens.

Authors:  Jody K Mays; Alexis Black-Pyrkosz; Tamer Mansour; Brian C Schutte; Shuang Chang; Kunzhe Dong; Henry D Hunt; Aly M Fadly; Lei Zhang; Huanmin Zhang
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

7.  A comprehensive analysis of avian lymphoid leukosis-like lymphoma transcriptomes including identification of LncRNAs and the expression profiles.

Authors:  Kunzhe Dong; Mohammad Heidari; Jody Mays; Shuang Chang; Qingmei Xie; Lei Zhang; Yongxing Ai; Huanmin Zhang
Journal:  PLoS One       Date:  2022-08-08       Impact factor: 3.752

Review 8.  Creation of diversity in the animal virus world by inter-species and intra-species recombinations: lessons learned from poultry viruses.

Authors:  Irit Davidson; Robert F Silva
Journal:  Virus Genes       Date:  2007-10-06       Impact factor: 2.198

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.